SCHEMBL14764466

SCHEMBL14764466

COc1cccc([N+](=O)[O-])c1NC(C)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
TDP1 Q9NUW8 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.46
MAPT P10636 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
POLB P06746 1/20 0.42
RAB9A P51151 1/20 0.42
TSHR P16473 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
CYP3A4 P08684 1/20 0.41
AR P10275 1/20 0.41
MEN1 O00255 1/20 0.41
GAA P10253 1/20 0.41
KMT2A Q03164 1/20 0.41
MAPK1 P28482 2/20 0.41
GLA P06280 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13555267 0.87 ALDH1A1 (0.52) ALDH1A1TDP1L3MBTL1MAPTPOLB
SCHEMBL14764513 0.85 L3MBTL1 (0.46) ALDH1A1TDP1L3MBTL1SMN1; SMN2POLB
SCHEMBL5115398 0.80 ALDH1A1 (0.56) ALDH1A1TDP1L3MBTL1MAPTSMN1; SMN2
SCHEMBL5115395 0.80 ALDH1A1 (0.56) ALDH1A1TDP1L3MBTL1MAPTSMN1; SMN2
SCHEMBL14764670 0.80 ALDH1A1 (0.46) ALDH1A1TDP1L3MBTL1MAPTSMN1; SMN2
Oxalic Acid SCHEMBL20984871 0.78 ALDH1A1 (0.53) ALDH1A1TDP1L3MBTL1MAPTSMN1; SMN2
SCHEMBL624954 0.77 PKM (0.47) ALDH1A1TDP1L3MBTL1MAPTSMN1; SMN2
SCHEMBL3449044 0.77 ALDH1A1 (0.56) ALDH1A1TDP1L3MBTL1MAPTPOLB
SCHEMBL6930910 0.76 ALDH1A1 (0.62) ALDH1A1TDP1L3MBTL1MAPTSMN1; SMN2
SCHEMBL20984873 0.76 ALDH1A1 (0.54) ALDH1A1TDP1L3MBTL1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013034755-A1 TRIAZOLOPYRAZINE DERIVATIVES AND THEIR USE FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS H. LUNDBECK A/S (DK) 2013-03-14 WO disclosed